Positive inotropic, positive chronotropic and coronary vasodilatory effects of rat amylin: Mechanisms of amylin-induced positive inotropy

Acta Physiologica Hungarica

Volumn 97, Issue 4, 2010, Pages 362-374

  Kaygisiz, Ziya ^a   Ozden, H ^a   Erkasap, N ^a   Koken, T ^a   Gunduz, T ^a   Ikizler, M ^b   Kural, T ^b  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^b AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

amylin; contractility; heart rate; perfusion pressure; signal transduction

Indexed keywords

AMYLIN; CALCIUM CHANNEL BLOCKING AGENT; CORONARY VASODILATING AGENT; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; DILTIAZEM; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C INHIBITOR; RYANODINE; STAUROSPORINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONOTROPISM; CONTROLLED STUDY; CORONARY ARTERY DILATATION; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HUMAN; INOTROPISM; MALE; NONHUMAN; PERFUSION PRESSURE; RAT; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, L-TYPE; CALCIUM SIGNALING; CORONARY CIRCULATION; CORONARY VESSELS; ENZYME ACTIVATION; FEMALE; HEART RATE; HUMANS; ISLET AMYLOID POLYPEPTIDE; MALE; MYOCARDIAL CONTRACTION; MYOCARDIUM; PERFUSION; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM; TIME FACTORS; VASODILATION; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 78650158274     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.97.2010.4.2     Document Type: Article

References (54)

1. 1-preferring receptors coupled to positive contractile response in rat ventricular cardiomyocytes. Regul. Pept. 60, 125-133 (1995)
2. 2+] during individual cardiac muscle contractions. Am. J. Physiol. 244, H462-H468 (1983)
3. Bers DM, Lederer WJ, Berlin JR: Intracellular Ca transients in rat cardiac myocytes: role of Na-Ca Exchange in excitation-contraction coupling. Am. J. Physiol. 258, C944-C954 (1990)
4. 2+ current cooperatively in human atrial myocytes. Am. J. Physiol. 278, H670-H676 (2000)
5. Brain SD, Wimalawansa S, Maclntyre I, Williams TJ: The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit. Am. J. Pathol. 136, 487-490 (1990)
6. Buck E, Zimanyi I, Abramson JJ, Pessah IN: Ryanodine stabilizes multiple conformational states of the skeletal muscle calcium release channel. J. Biol. Chem. 267, 23560-23567 (1992)
7. Canadian Council on Animal Care (1984): Guide to the Care and Use of Experimental Animals, CCAC, Ottawa, Vol. 2, pp. 176-187
8. 1 receptors. J. Pharmacol. Exp. Ther. 269, 989-992 (1994)
9. + transport and contractility in rat skeletal muscle. J. Physiol. 527, 121-130 (2000)
10. Cooper GJ: Amylin compared with calcitonin gene-related peptide: structure, biology and relevance to metabolic disease. Endocrine Rev. 15, 163-201 (1994)
11. Edwards BJ, Marley JE: Amylin. Life Sci. 51, 1899-1912 (1992)
12. 2+ transients in beating rat hearts. Am. J. Physiol. 286, H971-H978 (2004)
13. Fabiato A: Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am. J. Physiol. 245, C1-C14 (1983)
14. Fill M, Copello JA: Ryanodine receptor calcium release channels. Physiol. Rev. 82, 893-922 (2002)
15. Fink MA., Zakhary DR, Mackey JA, Desnoyer RW, Apperson-Hansen C, Damron DS, Bond M: AKAP-mediated targeting of protein kinase A regulates contractility in cardiac myocytes. Circ. Res. 88, 291-297 (2001)
16. Ganong WF (2005): Review of Medical Physiology. McGraw-Hill Companies, Appleton & Lange, Singapore, pp. 44-45
17. Gardiner SM, Compton AM, Kemp PA, Bennett T, Bose C, Foulkes R, Hughes B: Antagonistic effect of human alpha-calcitonin gene-related peptide (8-37) on regional hemodynamic actions of rat islet amyloid polypeptide in conscious Long-Evans rats. Diabetes 40, 948-951 (1991)
18. Golpon HA, Puechner A, Welte T, Wichert P V, Feddersen CO: Vasorelaxant effect of glucagon-like peptide-(7-36) amide and amylin on the pulmonary circulation of the rat. Regul. Pept. 102, 81-86 (2001)
19. Guiliani S, Wimalawansa SJ, Maggi CA: Involvement of multiple receptors in the biological effects of calcitonin gene-related peptide and amylin in rat and guinea-pig preparations. Br. J. Pharmacol. 107, 510-514 (1992)
20. Hain J, Onoue H, Mayrleitner M, Fleischer S, Schinder H: Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J. Biol. Chem. 270, 2074-2081 (1995)
21. Hasbak P, Sams A, Schifter S, Longmore J, Edvinsson L: CGRP receptors mediating CGRP-, adrenomedullin and amylin-induced relaxation in porcine coronary arteries. Characterization with 'compound1' (WO98/11138), a non-peptide antagonist. Br. J. Pharmacol. 133, 1405-1413 (2001)
22. He M-X, Downey HF: Downregulation of ventricular contractile function during early ischemia is fow but not pressure dependent. Am. J. Physiol. 275, H1520-H1523 (1993)
23. Hoogwerf BJ, Doshi KB, Diab D: Pramlintide, the synthetic analogue of amylin: physiology, pathophysiology, and effects on glycemic control, body weight, and selected biomarkers of vascular risk. Vasc. Health Risk Manag. 4, 355-362 (2008)
24. Hrnciar J: Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome. Vnitr. Lek. 42, 557-560 (1996)
25. 2+ transient in rat myocytes during β-adrenergic stimulation. J. Physiol. 505, 385-402 (1997)
26. Irvine JC, Favaloro JL, Kemp-Harper BK: NO-activates guanylate cyclase and Kv channels to vasodilate resistance arteries. Hypertens. 41, 1301-1307 (2003)
27. i in ventricular myocytes. Exp. Biol. Med. 231, 865-870 (2006)
28. Kranias EG, Garvey JL, Srivasta RD, Solaro RJ: Phosphorylation and functional modifcation of sarcoplasmic reticulum and myofbrils in isolated rabbit heart stimulated with isoprenaline. Biochem. J. 226, 113-121 (1985)
29. Lattanzio FA, Schlatterer RG, Nicar M, Campbell KP, Sutko JL: The effect of ryanodine on passive calcium fuxes across sarcoplasmic membranes. J. Biol. Chem. 262, 2711-2718 (1987)
30. 2+ sites. Clin. Exp. Pharmacol. Physiol. 34, 889-896 (2007)
31. Li Y, Kranias EG, Mignery GA, Bers DM: Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ. Res. 90, 309-316 (2002)
32. Luk'yantseva G V, Sergeev IY, Koplora GN, Samonina GE, German SV: Effect of amylin on the tone of rat aorta ring preparation. Bull. Exp. Biol. Med. 132, 932-934 (2001)
33. 2+ activation. J. Biol. Chem. 276, 39727-39735 (2001)
34. 2+ release channel of sarcoplasmic reticulum. J. Biol. Chem. 261, 6300-6306 (1986)
35. Meissner G: Molecular regulation of cardiac ryanodine receptor ion channel. Cell. Calcium 35, 621-628 (2004)
36. Morgan JP: Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N. Engl. J. Med. 325, 625-632 (1991)
37. - conductance in cardiac myocytes. Pfügers Arch. 438, 269-277 (1999)
38. Opgaard OS, deVries R, Tom B, Edvinsson L, Saxena PR: Positive inotropy of calcitonin gene-related peptide and amylin on porcine isolated myocardium. Eur. J. Pharmacol. 385, 147-154 (1999)
39. Opgaard OS, Hasbak P, deVries R, Saxena PR, Edvinsson L: Positive inotropy mediated via CGRP receptors in isolated human myocardial trabeculae. Eur. J. Pharmacol. 397, 373-382 (2000)
40. Pappalardo G, Milardi D, Magri A, Attanasio F, Impellizzeri G, La Rosa C, Grasso D, Rizzarelli E: Environmental factors differently affect human and rat IAPP: Conformational preferences and membrane interactions of IAPP17-29 peptide derivatives. Chemistry 13, 10204-10215 (2007)
41. 1 and salmon calcitonin. Regul. Pept. 117, 159-166 (2004)
42. Sheykhzade M, Nyborg NC: Characterization of calcitonin gene related peptide (CGRP) receptors in intramural coronary arteries from male and female Sprague Dawley rats. Br. J. Pharmacol. 123, 1464-1470 (1998)
43. Sheykhzade M, Nyborg NC: Non-competitive antagonism of amylin on CGRP(1)-receptors in rat coronary small arteries. Br. J. Pharmacol. 130, 386-390 (2000)
44. Simmerman HK, Jones LR: Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol. Rev. 78, 921-947 (1998)
45. 2+ currents via increased P13Kalpha/PKB signaling. Circ. Res. 98, 1390-1397 (2006)
46. Uwaifo GI, Ratner RE: Novel pharmacologic agents for type 2 diabetes. Endocrinol. Metab. Clin. North Am. 34, 155-197 (2005)
47. Villa I, DaI Fiume C, Maestroni A, Rubinacci A, Ravasi F, Guidobono F: Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity. Am. J. Physiol. 284, E627-E633 (2003)
48. Wang ZL, Bennet WM, Ghatei MA, Byfeld PG, Smith DM, Bloom SR: Infuence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes 42, 330-335 (1993)
49. Westfall TC, Curfman-Falvey M: Amylin-induced relaxation of the perfused mesenteric arterial bed: mediatation by calcitonin gene-related peptide receptors. J. Cardiovasc. Pharmacol. 26, 932-936 (1995)
50. 2+ current in guinea-pig ventricular myocytes. Pfügers Arch. 437, 335-344 (1999)
51. Wookey PJ, Cooper ME: Amylin: physiological roles in the kidney and a hypothesis for its role in hypertension. Clin. Exp. Pharmacol. Physiol. 25, 653-660 (1998)
52. Wookey PJ, Tikellis C, Du HC, Qin HF, Sexton PM, Cooper ME: Amylin binding in rat renal cortex, stimulation of adenylyl cyclase, and activation of plasma renin. Am. J. Physiol. 270, F289-F294 (1996)
53. Yang BC, Nichols WW, Mehta JL: Cardiac effect of acetylcholine in rat hearts: role of endothelium-derived relaxing factor and prostaglandins. Am. J. Physiol. 264, H1388-H1393 (1993)
54. Zahradnikova A, Minarovic I, Zahradnik I: Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists. J. Pharmacol. Exp. Ther. 322, 638-645 (2007)